Phase II study of oxaliplatin (OX), 5-fluorouracil (5-FU), and radiation therapy (RT) followed by gemicitabine (GEM) in patients with unresectable pancreatic cancer
- Citation:
- J Clin Oncol vol 26 (15s) abstr 15553
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 303
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- G. P. Kim M. Haddock N. R. Foster J. Bollinger P. J. Stella J. W. Kugler S. R. Alberts J. Martenson
- Networks:
- Study
- NCCTG-N0349
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: